John Celebi
2022
In 2022, John Celebi earned a total compensation of $1.6M as President and Chief Executive Officer at Sensei Biotherapeutics, a 77% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $228,016 |
|---|---|
| Option Awards | $537,420 |
| Salary | $512,500 |
| Stock Awards | $231,770 |
| Other | $59,176 |
| Total | $1,568,882 |
Celebi received $537.4K in option awards, accounting for 34% of the total pay in 2022.
Celebi also received $228K in non-equity incentive plan, $512.5K in salary, $231.8K in stock awards and $59.2K in other compensation.
Rankings
In 2022, John Celebi's compensation ranked 2,144th out of 5,676 executives tracked by ExecPay. In other words, Celebi earned more than 62.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,144 out of 5,676 | 62nd |
Division Manufacturing | 1,150 out of 3,084 | 63rd |
Major group Chemicals And Allied Products | 495 out of 1,399 | 65th |
Industry group Drugs | 455 out of 1,300 | 65th |
Industry Pharmaceutical Preparations | 328 out of 942 | 65th |
Source: SEC filing on June 15, 2023.
Celebi's colleagues
We found three more compensation records of executives who worked with John Celebi at Sensei Biotherapeutics in 2022.